Michelle M. Dugan, MD

Research Fellow
Cutaneous Oncology Department, Moffitt Cancer Center, Tampa, FL, United States

Presentation(s):

• 32: Isolated Limb Infusion as First, Second, or Third-Line Therapy for Melanoma with In-Transit Metastasis

  Monday, February 19, 2024
  8:10 AM - 8:20 AM AST

• 35: Hepatic and Overall Progression-Free Survival after Percutaneous Hepatic Perfusion as First-Line or Second-Line Therapy for Metastatic Uveal Melanoma

  Monday, February 19, 2024
  8:40 AM - 8:50 AM AST

• 43: Isolated Limb Infusion for Limb Threatening Sarcomas

  Monday, February 19, 2024
  9:30 AM - 9:40 AM AST